CTV News Feature

FlowLabs was recently featured on CTVNews.ca for the launch of its discreet, mail-in semen analysis kit, a first-of-its-kind service designed to improve access to male fertility testing for patients across Canada.

The article highlights longstanding challenges associated with in-clinic semen analysis, including long travel distances, limited availability of lab services, and logistical barriers that often lead patients to delay or forgo fertility testing altogether. These delays can have a meaningful impact on fertility outcomes, as semen analysis is typically the first and most essential diagnostic step for couples beginning fertility investigations.

Dr. Keith Jarvi, head of urology at Mount Sinai Hospital and director of the Murray Koffler Urologic Wellness Centre, spoke with CTV News about the importance of improving access to timely, lab-quality testing:
“A semen test is essentially the core test that couples would do to start the investigation for fertility, and fertility affects about 15 per cent of couples. This is a really big issue.”

Dr. Jarvi noted that many of his patients struggled to find laboratories capable of performing high-quality semen analysis close to home, emphasizing that samples must be analyzed quickly after collection to ensure accuracy.

To address this gap, FlowLabs’ engineering team developed a mail-in kit that delivers the same calibre of results as in-lab testing. Patients collect their sample at home and courier it to one of FlowLabs’ accredited laboratories in Toronto or Oshawa, where it arrives within two days for analysis. The test provides clinically reliable measurements of sperm count and motility, just as it would if conducted in person.

“The result is faster access to testing, which means quicker results and fewer logistical barriers for patients and partners,” FlowLabs shared in the release cited by CTV News.
In addition to semen analysis, FlowLabs offers a range of fertility-related diagnostics, including DNA fragmentation testing, post-ejaculation urine testing, aneuploidy testing, and post-vasectomy checks.

Dr. Jarvi explained that the goal behind the kit was to bring lab-quality testing into patients’ homes, particularly for those navigating Canada’s geography and wait times:

“This is trying to take the lab to the patients, as opposed to the patients to the lab.”

While mail-in testing requires careful adherence to collection instructions, Dr. Jarvi noted that the level of risk is comparable to other at-home diagnostic tests already in widespread use.

By reducing barriers to access and supporting earlier testing, the FlowLabs mail-in semen analysis kit empowers men and their partners to make informed decisions sooner — whether that means lifestyle changes, additional diagnostics, or specialist care.

We’re proud to be recognized by CTV News for our work to modernize fertility diagnostics and expand access to high-quality care for patients across Canada.

Read the full CTV News feature here.

FlowLabs Mail-In Semen Analysis Kit Featured in CBC News

FlowLabs Mail-In Semen Analysis Kit Featured in CBC News

January 13, 2026

FlowLabs was recently featured in CBC News for its new mail-in semen analysis testing kit, designed to improve access to fertility testing for men in rural and remote communities across Canada. 

The article highlights common barriers to in-clinic testing, such as long travel distances, limited lab availability, work schedules, and personal discomfort, that often cause delays to fertility treatment. It describes how the new mail-in kit addresses these barriers and how it works, including how it meets the same standards as traditional in-person lab testing. 

Dr. Jarvi, one of FlowLabs’ cofounders, was interviewed for the piece: 

“The goal was to shift to at-home care in order to improve access in rural and remote communities,” said Dr. Keith Jarvi, head of urology at Mount Sinai Hospital and director of the Murray Koffler Urologic Wellness Centre. 

He said access to male infertility testing has long been uneven across the province.   

“We have a problem in Ontario that we have difficulty accessing lab services for men with infertility because there aren’t that many places that do semen tests,” Jarvi said.  

“It’s been difficult for people who are not in one of the major centres to get testing done because you have to often travel for hours to get even a simple semen test done.”

The article also quotes FlowLabs’ president Murray Kline: 

“As I understand it, it is a first of its kind being able to deliver a laboratory-quality test for semen analysis where the patient is able to courier the sample back to us,” Kline said.”

We’re proud to be recognized by CBC News for our efforts to expand access to fertility care across the country. 

Read the full CBC feature here. 

Lab launches Canada’s first mail-in semen analysis kit

Lab launches Canada’s first mail-in semen analysis kit

January 15, 2026

FlowLabs was recently featured on CP24 for the launch of its new discreet, mail-in semen analysis kit, designed to improve access to male fertility testing for patients across Canada.

The CP24 coverage highlights a long-standing challenge in fertility care: while semen analysis is often the first and most essential diagnostic step for couples beginning fertility investigations, many patients still face major logistical barriers to completing this testing—especially when they live far from qualified labs, have limited appointment availability, or experience discomfort with in-clinic collection.

Dr. Keith Jarvi, head of urology at Mount Sinai Hospital and director of the Murray Koffler Urologic Wellness Centre, emphasized why removing delays matters. In the CP24 feature, he underscored the central role semen analysis plays in fertility assessment and how access challenges can stall care at a critical moment.

To help close that gap, FlowLabs’ engineering team developed a mail-in kit that supports lab-quality semen analysis from home—allowing patients to collect their sample privately and ship it to FlowLabs laboratories for timely processing. The kit measures key indicators such as sperm count and motility, with the aim of delivering results comparable to traditional in-lab testing while reducing barriers tied to geography and wait times.

As FlowLabs noted in its materials, the impact is straightforward: faster access to testing can mean quicker results and fewer logistical hurdles for patients and their partners.

Dr. Jarvi also captured the intent behind the service in a single idea:
FlowLabs was recently featured on CP24 for the launch of its new discreet, mail-in semen analysis kit, designed to improve access to male fertility testing for patients across Canada.

The CP24 coverage highlights a long-standing challenge in fertility care: while semen analysis is often the first and most essential diagnostic step for couples beginning fertility investigations, many patients still face major logistical barriers to completing this testing—especially when they live far from qualified labs, have limited appointment availability, or experience discomfort with in-clinic collection.

Dr. Keith Jarvi, head of urology at Mount Sinai Hospital and director of the Murray Koffler Urologic Wellness Centre, emphasized why removing delays matters. In the CP24 feature, he underscored the central role semen analysis plays in fertility assessment and how access challenges can stall care at a critical moment.

To help close that gap, FlowLabs’ engineering team developed a mail-in kit that supports lab-quality semen analysis from home—allowing patients to collect their sample privately and ship it to FlowLabs laboratories for timely processing. The kit measures key indicators such as sperm count and motility, with the aim of delivering results comparable to traditional in-lab testing while reducing barriers tied to geography and wait times.

As FlowLabs noted in its materials, the impact is straightforward: faster access to testing can mean quicker results and fewer logistical hurdles for patients and their partners.
Dr. Jarvi also captured the intent behind the service in a single idea:

“This is trying to take the lab to the patients, as opposed to the patients to the lab.”
We’re proud to see CP24 recognizing this step forward in male fertility diagnostics—and the role accessible testing can play in helping couples make earlier, more informed decisions.

Read the CP24 feature here